Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
Improving the quality of spiritual care as a dimension of palliative care: the report of the Consensus Conference.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS. Neurology. 2010 Jun 08; 74(23):1877-85.
View in:
PubMed
subject areas
Adjuvants, Immunologic
Adult
Antibodies
Cross-Sectional Studies
Disability Evaluation
Dose-Response Relationship, Drug
Female
Follow-Up Studies
Humans
Interferon beta-1b
Interferon-beta
Longitudinal Studies
Magnetic Resonance Imaging
Male
Middle Aged
Multiple Sclerosis, Relapsing-Remitting
Survival Analysis
Time Factors
authors with profiles
Anthony T. Reder